Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.
暂无分享,去创建一个
M. Piccart | M. Nooij | R. Paridaens | D. Cameron | L. Duchateau | L. Dirix | L. Beex | C. Lohrisch | T. Čufer | J. Lobelle | A. Hamilton | L. Biganzoli | Martine Piccart | Luc Dirix | Caroline Lohrisch | David Cameron | Tanja Cufer | Martine Piccart | David Cameron | Luc Dirix